Fund Evaluator:
Roundhill GLP-1 & Weight Loss ETF (OZEM)
Follow This Fund
Equity
Global Asset Class
Sector Equity
Fund Group
Health
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.59% D
Expense Ratio
$61 Mil
Assets
Open
Status
0.00%
12b-1 Fee
1.29%
TTM Yield
0.00%
Max Load
66%
Portfolio Turnover
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Data as of 7/31/2026
-1.8% D
1-Mo Return
2.6% F
3-Mo Return
-6.7% F
YTD Return
32.7% C
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Roundhill Investments
Inception Date
5/20/2024
Share Class Type
Equity Investment Style
Large-Cap
Value
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
Solactive GBS Global Mkt All Cap TR USD: 100%
Additional Fund Details
Roundhill GLP-1 & Weight Loss ETF Overview
OZEM Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| OZEM Return (NAV) | -1.8% | 2.6% | 32.7% | na | na | na |
| OZEM Grade | D | F | C | na | na | na |
| +/- Category | -1.4% | -8.1% | -1.1% | na | na | na |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| OZEM Tax Cost Ratio | na | na | 0.5% | na | na | na |
OZEM Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| OZEM Return (NAV) | -6.7% | 41.4% | na | na | na | na | na | na | na | na | na |
| OZEM Grade | F | A | na | na | na | na | na | na | na | na | na |
| +/- Category | -13.8% | 20.8% | na | na | na | na | na | na | na | na | na |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Value |
| Bond Investment Style: | na |
| Yield: | 1.3% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $61 Mil |
| Fund Total Assets: | $ 61 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 66% |
Management Team
| Number of Managers: 7 | |||
| Longest Tenure: 2.2 years | |||
| Average Tenure: 2.2 years | |||
| Managers (Year): Hershey William (2024), Serowik Andrew (2024), Maloney Timothy (2024), Tan Gabriel (2024), Alberico Todd (2024), Cooper Brian (2024), Mazza David (2024) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 28 |
| % in Top 10 Holdings: | 64.6% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 56.8% |
Portfolio Allocation |
|
| Domestic Stock: | 42.5% |
| Foreign Stock: | 56.8% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.3% |
| Cash: | 0.5% |
Purchase Information
| Fund Family: | Roundhill Investments |
| Phone Number: | 855-561-5728 |
| Website: |
| Status: | Open |
| Inception Date: | May 20, 2024 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 0.59% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Roundhill GLP-1 & Weight Loss ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.